Featured ArticleFrequent EPHA2 receptor mutations in cholangiocarcinoma disrupt receptor forward signaling supporting a tumor suppressor roleAuthorCommunicationsDateDecember 8, 2025Share Bluesky Facebook Linkedin Reddit Email Copy URL